Skip to main content
. 2019 Oct 1;10(5):e02211-19. doi: 10.1128/mBio.02211-19

FIG 6.

FIG 6

Activation of AMPK in skeletal muscle following 2-AA treatment. (Top) Representative immunoblots of pAMPKβ1 (Ser182) in skeletal muscle 1 day, 2 days, and 4 days after 2-AA treatment and 2-AA-plus-NAC treatment. AMPKβ1/2 was used as a control. (Bottom) Histograms show the relative expression levels of proteins. n = 5 in each group; data represent means ± SD. P < 0.05, one-way ANOVA.